SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: VLAD who wrote (11246)7/11/1998 5:08:00 PM
From: AlienTech  Read Replies (1) | Respond to of 23519
 
>>Other than complain that the FDA should not have fast track approved Viagra and PFE should have included a more "at risk" pool in their studies, does this group have much political leverage in Washington?<<

How well do you know of the deaths related to the vietnam protests and blockade of manhatten island? Ofcourse they werent americans, they were protestors and traitors.
Does it even exists?
And everyone makes such a big deal of the the chinese schwazan beef masacare where people were run over by tanks. The US is much neater, they just shoot you.
When people go against big money, money always wins, ofcourse depends on whos money, when the tobacco related health problems became more than what the industry was paying them guess who won.



To: VLAD who wrote (11246)7/12/1998 9:08:00 AM
From: BigKNY3  Read Replies (2) | Respond to of 23519
 
To the investigative team of Vladwood and Zebstein:

Have you considered tracking the movements of Paine Webber accounts in VVUS from Monday to Friday last week?

Here is a summary of the VVUS price action and milestones for your background:

BigKNY3

Date.......Shares.......High....Low..........Close
07/02/98..642,000.......6 ......5 3/4.......5 13/16
07/06/98..1,827,500.....7 1/4...5 13/16.....6 7/8
07/07/98..8,244,600.....10......7 3/4.......10
07/08/98..5,190,900.....10 1/4...8 1/2......9 3/16
07/09/98..3,272,200.....8 13/16...7 5/8.....7 3/4
07/10/98..5,875,200.....6 15/16...6 1/4 .....6 1/2

Monday: VVUS raises on heavy volume on no news and flat Rxs
Tuesday: Paine Webber ( a market maker for VVUS) issues an upgrade to buy from neutral. www3.techstocks.com

1. We are raising our rating on the shares of Vivus* to buy from
neutral, reflecting what we believe to be the beginnings of a turn in
new prescriptions and recent FDA approval for domestic shipments from
its new 90,000 square-foot manufacturing facility.
2. Moreover, we sense that the company may be on the verge of announcing plans to dramatically reduce costs and even restructure its sales organization.
3. If domestic demand rebounds as we are forecasting and costs trend
lower, we believe that Vivus can deliver earnings per share of $1.00
next year. Were this dramatic a turnaround to occur, VVUS could, we
think, reach $20 within a year.

Wednesday (After the close): VVUS issues restructuring press release

Thursday(After the close): VVUS issues earnings report and conducts conference call.